New Hope for Pulmonary Hypertension
Science Magazine,
The FDA has just approved the first drug (sotatercept) to target the real mechanism behind pulmonary arterial hypertension, and…
The FDA has just approved the first drug (sotatercept) to target the real mechanism behind pulmonary arterial hypertension, and…
Phosphodiesterase type 5 (PDE5) inhibitors were found to have statistical and clinical benefits for World Health Organization (WH…